Rahul Kanabar, Jorge Barriuso, Mairéad G. McNamara, Was Mansoor, Richard A. Hubner, Juan W. Valle & Angela Lamarca. (2021) Liver Embolisation for Patients with Neuroendocrine Neoplasms: Systematic Review. Neuroendocrinology 111:4, pages 354-369.
Crossref
Malgorzata M Bala, Robert P Riemsma, Robert Wolff, Michal Pedziwiatr, Jerzy W Mitus, Dawid Storman, Mateusz J Swierz & Jos Kleijnen. (2019) Cryotherapy for liver metastases. Cochrane Database of Systematic Reviews.
Crossref
Kjell Öberg. 2016. Endocrinology: Adult and Pediatric. Endocrinology: Adult and Pediatric
2615
2627.e3
.
Maria Rosario Ferreira & Barbara H. Jung. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology
1324
1345
.
Maxime Palazzo, Catherine Lombard-Bohas, Guillaume Cadiot, Tamara Matysiak-Budnik, Vinciane Rebours, Marie-Pierre Vullierme, Anne Couvelard, Olivia Hentic & Philippe Ruszniewski. (2013) Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors. European Journal of Gastroenterology & Hepatology 25:2, pages 232-238.
Crossref
Kjell Öberg. (2012) Biotherapies for GEP-NETs. Best Practice & Research Clinical Gastroenterology 26:6, pages 833-841.
Crossref
Saboor Khan, David M. Nagorney & Florencia G. Que. 2012. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract
1305
1318.e3
.
Kjell ÖbergKjell Öberg. 2011. Advances in Neuroendocrine Tumor Management. Advances in Neuroendocrine Tumor Management
64
70
.
Mohid S Khan & Martyn E Caplin. (2011) Therapeutic management of patients with gastroenteropancreatic neuroendocrine tumours. Endocrine-Related Cancer 18:S1, pages S53-S74.
Crossref
A. Valatsou & M. Tzanela. (2011) Gastrointestinal neuroendocrine tumours. Management of unresectable disease and non-surgical treatment options. Hellenic Journal of Surgery 83:1, pages 21-28.
Crossref
Hank S Wang, David S Oh, Gordon V Ohning & Joseph R Pisegna. (2006) Cyto-reduction of neuroendocrine tumours using Sandostatin LAR® in combination with Infergen®: results of a case series. Journal of Pharmacy and Pharmacology 58:12, pages 1623-1628.
Crossref
Barbro Eriksson & Kjell Öberg. 2010. Endocrinology. Endocrinology
2774
2786
.
C Swärd, V Johanson, E Nieveen van Dijkum, S Jansson, O Nilsson, B Wängberg, H Ahlman & L Kölby. (2009) Prolonged survival after hepatic artery embolization in patients with midgut carcinoid syndrome. British Journal of Surgery 96:5, pages 517-521.
Crossref
K. Öberg. 2010. Management of Rare Adult Tumours. Management of Rare Adult Tumours
539
550
.
M. Ducreux, É. Baudin & C. Lombard-Bohas. 2008. Tumeurs endocrines thoraciques et digestives. Tumeurs endocrines thoraciques et digestives
215
232
.
U. Plöckinger & B. Wiedenmann. (2007) Treatment of gastroenteropancreatic neuroendocrine tumors. Virchows Archiv 451:S1, pages 71-80.
Crossref
Byron E. Wright, Chris C. Lee & Anton J. Bilchik. (2007) Hepatic Cytoreductive Surgery for Neuroendocrine Cancer. Surgical Oncology Clinics of North America 16:3, pages 627-637.
Crossref
U. Plöckinger & B. Wiedenmann. (2007) Biotherapy. Best Practice & Research Clinical Endocrinology & Metabolism 21:1, pages 145-162.
Crossref
. 2007. Surgery of the Liver, Biliary Tract and Pancreas. Surgery of the Liver, Biliary Tract and Pancreas
1178
1217
.
Ramon Salazar, Carlos Villabona & Joan Fabregat. (2006) Tumores neuroendocrinos gastrointestinales y pancreáticos. Medicina Clínica 127:6, pages 227-231.
Crossref
Chandrajit P. Raut, Matthew H. Kulke, Jonathan N. Glickman, Richard S. Swanson & Stanley W. Ashley. (2006) Carcinoid Tumors. Current Problems in Surgery 43:6, pages 391-450.
Crossref
Peter Simon, Elisabeth Spilcke-Liss & Henri Wallaschofski. (2006) Endocrine Tumors of the Pancreas. Endocrinology and Metabolism Clinics of North America 35:2, pages 431-447.
Crossref
Irvin M. Modlin, Igor Latich, Mark Kidd, Michelle Zikusoka & Geeta Eick. (2006) Therapeutic Options for Gastrointestinal Carcinoids. Clinical Gastroenterology and Hepatology 4:5, pages 526-547.
Crossref
María González Cao, Gorka Bastarrika, Jesús García-Foncillas, Javier Aristu, Ana Chopitea & Salvador Martín Algarra. (2006) Ileal carcinoid tumor with liver metastases and cardiac involvement treated with intraarterial liposomal doxorubicin and valve replacement. Clinical and Translational Oncology 8:5, pages 369-371.
Crossref
Willscott E. Naugler & Gordon C. Hunt. 2006. Endoscopic Oncology. Endoscopic Oncology
161
172
.
T. Aparicio, S. Dominguez-Tinajero & E. Mitry. 2006. Les cancers digestifs. Les cancers digestifs
219
240
.
U. Plöckinger & B. Wiedenmann. (2005) Management of metastatic endocrine tumours. Best Practice & Research Clinical Gastroenterology 19:4, pages 553-576.
Crossref
Tahir Shah & Martyn Caplin. (2005) Biotherapy for metastatic endocrine tumours. Best Practice & Research Clinical Gastroenterology 19:4, pages 617-636.
Crossref
Irvin M. Modlin, Mark Kidd, Igor Latich, Michelle N. Zikusoka & Michael D. Shapiro. (2005) Current Status of Gastrointestinal Carcinoids. Gastroenterology 128:6, pages 1717-1751.
Crossref
T.D. Atwell, J.W. Charboneau, F.G. Que, J. Rubin, B.D. Lewis, D.M. Nagorney, M.R. Callstrom, M.A. Farrell, H.C. Pitot & T.J. Hobday. (2005) Treatment of Neuroendocrine Cancer Metastatic to the Liver: The Role of Ablative Techniques. CardioVascular and Interventional Radiology 28:4, pages 409-421.
Crossref
Nicola Fazio. (2005) Should interferon-α and somatostatin analogs be combined in gastroenteropancreatic neuroendocrine tumor therapy?. Therapy 2:2, pages 229-235.
Crossref
Nicola Fazio. (2005) Should interferon- and somatostatin analogs be combined in gastroenteropancreatic neuroendocrine tumor therapy?. Therapy 2:2, pages 229-235.
Crossref
Göran Åkerström, Per Hellman, Ola Hessman & Liliana Osmak. (2005) Management of midgut carcinoids. Journal of Surgical Oncology 89:3, pages 161-169.
Crossref
K. Öberg. (2004) Management of neuroendocrine tumours. Annals of Oncology 15, pages iv293-iv298.
Crossref
Gregory A. Kaltsas, G. Michael Besser & Ashley B. Grossman. (2004) The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors. Endocrine Reviews 25:3, pages 458-511.
Crossref
Ulrich-Frank Pape & Bertram Wiedenmann. (2003) Adding interferon-α to octreotide slows tumour progression compared with octreotide alone but evidence is lacking for improved survival in people with disseminated midgut carcinoid tumours. Cancer Treatment Reviews 29:6, pages 565-569.
Crossref
L Kölby, G Persson, S Franzén & B Ahrén. (2003) Randomized clinical trial of the effect of interferon α on survival in patients with disseminated midgut carcinoid tumours. British Journal of Surgery 90:6, pages 687-693.
Crossref
Sundar Santhanam, Marios Decatris & Ken O??Byrne. (2002) Potential of Interferon-?? in Solid Tumours. BioDrugs 16:5, pages 349-372.
Crossref
I. Elizalde & F. Borda. (2002) Tratamiento actual del tumor carcinoide. Gastroenterología y Hepatología 25:8, pages 508-513.
Crossref
K. Öberg. (2001) Chemotherapy and biotherapy in the treatment of neuroendocrine tumours. Annals of Oncology 12, pages S111-S114.
Crossref
H. Ahlman, R. Arnold, H. D. Becker, J. Beyer, O. Kisker, G. Klöppel, K. J. Klose, U. Pies, H. D. Röher, R. Rothmund, S. Schneider, B. Simon, D. Simon, B. Stinner, M. Rothmund & R. K. Teichmann. 2000. Praxis der Viszeralchirurgie. Praxis der Viszeralchirurgie
445
553
.
Margareta Frank, Klaus J Klose, Matthias Wied, Natascha Ishaque, Carmen Schade-Brittinger & Rudolf Arnold. (1999) Combination Therapy With Octreotide and α-Interferon:. American Journal of Gastroenterology 94:5, pages 1381-1387.
Crossref
Robert J. Pelley & Ronald M. Bukowski. (1999) Recent advances in systemic therapy for gastrointestinal neuroendocrine tumors. Current Opinion in Oncology 11:1, pages 32.
Crossref
Y Zhou, A Gobl, S Wang, M.B Jacobsen, E.T Janson, G.K Haines III, J.A Radosevich & K Oberg. (1998) Expression of p68 protein kinase and its prognostic significance during IFN-α therapy in patients with carcinoid tumours. European Journal of Cancer 34:13, pages 2046-2052.
Crossref
B. K. Eriksson, E. G. Larsson, B. M. Skogseid, A. M. L�fberg, L. E. L�relius & K. E. �berg. (1998) Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors. Cancer 83:11, pages 2293-2301.
Crossref
Kjell Öberg. (1998) Carcinoid Tumors: Current Concepts in Diagnosis and Treatment. The Oncologist 3:5, pages 339-345.
Crossref
Muhammed Ashraf Memon & Heidi Nelson. (1997) Gastrointestinal carcinoid tumors. Diseases of the Colon & Rectum 40:9, pages 1101-1118.
Crossref